National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical lipidology Jg. 9; H. 6; S. S1 - S122.e1
Hauptverfasser: Jacobson, Terry A., Maki, Kevin C., Orringer, Carl E., Jones, Peter H., Kris-Etherton, Penny, Sikand, Geeta, La Forge, Ralph, Daniels, Stephen R., Wilson, Don P., Morris, Pamela B., Wild, Robert A., Grundy, Scott M., Daviglus, Martha, Ferdinand, Keith C., Vijayaraghavan, Krishnaswami, Deedwania, Prakash C., Aberg, Judith A., Liao, Katherine P., McKenney, James M., Ross, Joyce L., Braun, Lynne T., Ito, Matthew K., Bays, Harold E., Brown, W. Virgil
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.11.2015
Schlagworte:
Adherence
Adolescent
Adult
Aged
Cardiovascular
Child
Children
Clinical recommendations
Dyslipidemia
Dyslipidemias - diet therapy
Dyslipidemias - drug therapy
Dyslipidemias - therapy
Elderly
Female
Human immunodeficiency virus
Humans
Lifestyle therapies
Male
Middle Aged
Patient-Centered Care
Pregnancy
Residual risk
Rheumatoid arthritis
Team-based care
Young Adult
Adherence
Residual risk
Rheumatoid arthritis
Dyslipidemia
Team-based care
Lifestyle therapies
Children
Human immunodeficiency virus
Clinical recommendations
Elderly
ISSN:1933-2874, 1876-4789
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
ISSN:1933-2874
1876-4789
DOI:10.1016/j.jacl.2015.09.002